ibandronate sodium
Generic: ibandronate sodium
Labeler: mylan institutional llcDrug Facts
Product Profile
Brand Name
ibandronate sodium
Generic Name
ibandronate sodium
Labeler
mylan institutional llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ibandronate sodium 3 mg/3mL
Manufacturer
Identifiers & Regulatory
Product NDC
67457-524
Product ID
67457-524_270c89b1-757a-41ef-8067-d9034a4bdc9e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202671
Marketing Start
2014-09-02
Marketing End
2026-05-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67457524
Hyphenated Format
67457-524
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ibandronate sodium (source: ndc)
Generic Name
ibandronate sodium (source: ndc)
Application Number
ANDA202671 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 3 mg/3mL
Packaging
- 1 SYRINGE, GLASS in 1 CARTON (67457-524-33) / 3 mL in 1 SYRINGE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "270c89b1-757a-41ef-8067-d9034a4bdc9e", "openfda": {"unii": ["J12U072QL0"], "rxcui": ["904952"], "spl_set_id": ["a70566e1-cbe5-472a-85ae-08a14117552a"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (67457-524-33) / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "67457-524-33", "marketing_end_date": "20260531", "marketing_start_date": "20140902"}], "brand_name": "ibandronate sodium", "product_id": "67457-524_270c89b1-757a-41ef-8067-d9034a4bdc9e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "67457-524", "generic_name": "ibandronate sodium", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ibandronate sodium", "active_ingredients": [{"name": "IBANDRONATE SODIUM", "strength": "3 mg/3mL"}], "application_number": "ANDA202671", "marketing_category": "ANDA", "marketing_end_date": "20260531", "marketing_start_date": "20140902"}